MedTrace Logo

Swaziland HIV Incidence Measurement Survey 2

NCT04117984 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 15429

Last updated 2023-02-09

No results posted yet for this study

Summary

The second Swaziland HIV Incidence Measurement Survey (SHIMS 2, 2016), is a population based HIV Impact Assessment (PHIA) that will assess the prevalence of key human immunodeficiency virus (HIV)-related health indicators. This is a two-stage cluster sampled cross-sectional survey of 6,417 randomly selected households in Swaziland. Approximately 20,292 eligible persons will be approached (4,664 participants 0-14 years; 12,563 participants 15-49 years; 3,065 participants 50 years and older). Of the sample approached, 15,403 are expected to agree to a blood draw for home-based HIV rapid testing including 3,361 participants 0-14 years; 9,680 participants 15-49 years; and 2,362 participants 50 years and older. SHIMS 2, 2016 will characterize HIV incidence, prevalence, viral load suppression, cluster of differentiation 4 (CD4) T-cell distribution, and risk behaviors in a household-based, nationally-representative sample of the Swazi population and will describe uptake of key HIV prevention, care, and treatment services.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Jessica Justman, MD · Columbia University

  • David Hoos, MD · Columbia University

  • Harriet Nuwagaba-Biribonwoha, MD · Columbia University

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-08-30
Primary Completion
2017-12-31
Completion
2019-12-31

Countries

  • Eswatini

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04117984 on ClinicalTrials.gov